SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-21-020422
Filing Date
2021-08-18
Accepted
2021-08-18 17:00:52
Documents
17
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A cenb20210630_10qa.htm   iXBRL 10-Q/A 38183
2 EXHIBIT 31.1 ex_276959.htm EX-31.1 8177
3 EXHIBIT 31.2 ex_276964.htm EX-31.2 8536
4 EXHIBIT 32.1 ex_276965.htm EX-32.1 3778
5 EXHIBIT 32.2 ex_276966.htm EX-32.2 3788
  Complete submission text file 0001437749-21-020422.txt   226889

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA noticker-20210630.xsd EX-101.SCH 3625
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20210630_def.xml EX-101.DEF 13354
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20210630_lab.xml EX-101.LAB 18038
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20210630_pre.xml EX-101.PRE 13789
10 EXTRACTED XBRL INSTANCE DOCUMENT cenb20210630_10qa_htm.xml XML 3458
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55557 | Film No.: 211187328
SIC: 2834 Pharmaceutical Preparations